Senologie - Zeitschrift für Mammadiagnostik und -therapie, Table of Contents Rofo 2024; 21(01): 17-18DOI: 10.1055/a-2229-2827 Für Sie referiert Kommentar zu „MAMMA–Kontralaterales Mammakarzinom im MRT bei Frauen mit DCIS“Contributor(s): Evelyn Wenkel 1 Radiologie München, München, Deutschland › Author AffiliationsRecommend Article Abstract Buy Article Comment on:MAMMA – Kontralaterales Mammakarzinom im MRT bei Frauen mit DCISRofo 2023; 195(12): 1069-1069DOI: 10.1055/a-2093-4943 Full Text References Literatur 1 Brennan ME, McKessar M, Snook K. et al. Impact of selective use of breast MRI on surgical decision-making in women with newly diagnosed operable breast cancer. . The Breast 2017; 32: 135-143 2 Duffy SW, Dibden A, Michalopoulos D. et al. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.. Lancet Oncol 2016; 17: 109-114 3 Narod SA, Iqbal J, Giannakeas V. et al. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.. JAMA Oncol 2015; 1: 888 4 Keymeulen KBIM, Geurts SME, Kooreman LFS. et al. Clinical value of contralateral breast cancers detected by pre-operative MRI in patients diagnosed with DCIS: a population-based cohort study.. Eur Radiol 2022; 33: 2209-2217 5 Wang SY, Long JB, Killelea BK. et al. Preoperative breast magnetic resonance imaging and contralateral breast cancer occurrence among older women with ductal carcinoma in situ.. Breast Cancer Res Treat 2016; 158: 139-148